Selected Publications

Elise A. Chong 1, Emeline R. Chong 1, Dylan Therwhangher 1, Sunita D. Nasta 1, Daniel J. Landsburg 1, Stefan K. Barta 1, Jakub Svoboda 1, James N. Gerson 1, Guido Ghilardi 1, Luca Paruzzo 1, Joseph A. Fraietta 1, Elizabeth Weber 1, Natalie Stefano 1, David L. Porter 1, Noelle V. Frey 1, Alfred L. Garfall 1, Marco Ruella 1, Stephen J. Schuster 1: Bendamustine as lymphodepletion for brexucabtagene autoleucel therapy of mantle cell lymphoma. Transplantation & Cellular Therapy Journal March 2024 Notes: Ref: JTCT57380.

Elise A. Chong, Stephen J. Schuster, John P. Plastaras, Goldie Kurtz, Wisdom Akingbemi, Nikhil Yegya-Raman: Stereotactic radiotherapy and CART for treatment of secondary CNS lymphoma. Leukemia & Lymphoma March 2024.

Elise A Chong, MD, Kingsley Gideon Kumashie, PhD, Emeline R Chong, BA, Joseph Fabrizio, BS, Aditi Gupta, MD, Jakub Svoboda, MD, Stefan K Barta, MD, Kristy M Walsh, BS, Ellen B Napier, CRNP, Rachel K Lundberg, PA-C, Sunita D Nasta, MD, James N Gerson, MD, Daniel J Landsburg, MD, Joyce Gonzalez, BS, Andrew Gaano, BS, Madison E Weirick, BS, Christopher M McAllister, BS, Moses Awofolaju, BA, Gavin N John, Shane C Kammerman, Josef Novaceck, Raymone Pajarillo, MS, Kendall A Lundgreen, PhD, Nicole Tanenbaum, BA, Sigrid Gouma, PhD, Elizabeth M Drapeau, PhD, Sharon Adamski, MS, Kurt D’Andrea, BS, Ajinkya Pattekar, MD, Amanda Hicks, BS, Scott Korte, BS, Harsh Sharma, MS, Sarah Herring, BS, Justine C Williams, BS, Jacob T Hamilton, MS, Paul Bates, PhD, Scott E Hensley, PhD, Eline T Luning Prak, MD, PhD, Allison R Greenplate, PhD, E John Wherry, PhD, Stephen J Schuster, MD, Marco Ruella, MD, Laura A Vella, MD, PhD: Immunologic predictors of vaccine responsiveness in patients with lymphoma and CLL. The Journal of Infectious Diseases March 2024.

David M. Weiner, Supriya Rastogi, Daniel J. Lewis, Leah Cohen, Sara Choi, Carmela C. Vittorio, Paul L. Haun, Sara S. Samimi, Jennifer Villasenor-Park, Rahul S. Bhansali, Elise A. Chong, Daniel J. Landsburg, Sunita D. Nasta, Stephen J. Schuster, Jakub Svoboda, Ellen J. Kim, Alain H. Rook, Stefan K. Barta 3: Mogamulizumab Multimodality Therapy with Systemic Retinoids, Interferon, or Extracorporeal Photopheresis for Advanced Cutaneous T-Cell Lymphoma Dermatologic Therapy 2023, December 2023.

Adam S Kittai, MD1, Ying Huang, MS, MA1, Sarah Miller, BS2*, John N. Allan, MD3, Seema A Bhat, MD1, David A. Bond, MD, BS4, Danielle M Brander, MD5, John C. Byrd, MD6, Julio C Chavez, MD7, Elise A. Chong, MD8, Matthew S. Davids, MD, MMSc9, Alexey Danilov, MD10, Wei Ding, MD, PhD11, Mark R Dowling, MBBS, PhD12*, Kaitlyn M. Dvorak-Kornaus, PhD1*, Hannah Freedman, RN9*, Paul J Hampel, MD11, Carrie I Ho, MD13, Steven R Hwang, MD11, Prioty Islam, MD14*, Nitin Jain, MD15, Matthew Matasar, MD, MS16, Cecelia Miller, PhD17*, Erin M Parry, MD, PhD9, Kari G. Rabe, MS18*, Manoj Rai, MD19*, Phil Raess, MD, PhD20*, Lindsey E. Roeker, MD14, Joanna M. Rhodes, MD21, Kerry A Rogers, MD1, Aditi Saha, MBBS22, Jake Schade, BA16*, Hamish S Scott, PhD, BSc12, Mazyar Shadman, MD, MPH13, Geoffrey P. Shouse, PhD, DO23, Alan Skarbnik, MD24, Stephen E Spurgeon, MD25, Deborah M. Stephens, DO26, Meghan C. Thompson, MD14, Philip A. Thompson, MBBS27*, Yucai Wang, MD, PhD11, William G. Wierda, MD, PhD28, Max Yano, MD, PhD29*, Omer Zulfa, MD6*, Jennifer A. Woyach, MD1: Outcomes of Patients with Richter Transformation without Prior Chemoimmunotherapy for CLL/SLL: An International Multicenter Retrospective Study To be updated (497), Dec 2023 Notes: Oral Presentation at ASH 2023, Abstract #497.

Muenzen RM, Chong ER, Therwhanger D, Landsburg DJ, Nasta SD, Svoboda J, Barta SK, Hughes ME, Weber E, Ruella M, Frey NV, Porter DL, Schuster SJ, Chong EA: Safety of CAR-T Cell Therapy in Asymptomatic Patients with Positive Respiratory Viral Testing Prior to CAR-T Infusions To be updated (2341), Dec 2023 Notes: Poster Presentation.

Chong EA, Penuel E, Bartlett NL, Bosch F, Budde LE, Fay K, Flinn IW, Goy A, Kumar A, Lundberg R, Napier EB, Nastoupil LJ, Shadman M, Wei MC, Wu M, Yin S, Chong ER, Schuster SJ: Response to Mosunetuzumab in Patients with B-Cell Lymphomas Relapsed or Refractory after CAR-T Cell Therapy Is Associated with Changes in Lymphocyte Counts To be updated(1752), Dec 2023 Notes: ASH 2023 Poster Presentation.

Bair SM, Narkhede M, Frosch ZAK, Chong EA, Ermann DA, Isufi I, Awan FT, Chavez JC, Bosma GN, Abbott D: Treatment Intensity and Outcomes in Elderly Patients with DLBCL Receiving First Line Therapy. To be updated(68), Dec 2023 Notes: Oral Presentation at ASH 2023, Abstract #68.

Bowers JT, Anna J, Bair SM, Annunzio K, Epperla N, Pullukkara JJ, Gaballa S, Spinner MA, Li S, Messmer MR, Nguyen J, Ayers EC, Wagner CB, Hu B, Di M, Huntington SF, Furqan F, Shah NN, Chen C, Ballard HJ, Hughes ME, Chong EA, Nasta SD, Barta SK, Landsburg DJ, Svoboda J.: Brentuximab vedotin plus AVD for Hodgkin lymphoma: incidence and management of peripheral neuropathy in a multisite cohort. Blood Adv 7: 6630-6638, Nov 2023.

Landsburg DJ, Morrissette JJD, Nasta SD, Barta SK, Schuster SJ, Svoboda J, Chong EA, Bagg A.: TP53 mutations predict for poor outcomes in patients with newly-diagnosed aggressive B cell lymphomas in the current era. Blood Advances Oct 2023 Notes: Accepted for publication.